Abstract
Abstract Objective In this study, mannan-binding lectin-associated serine protease 2 (MASP2) gene variant was evaluated to assess the risk of radiation pneumonitis (RP) in patients with pulmonary malignancies. Methods A total of 169 lung cancer patients with radiotherapy were included in our prospective study (NCT02490319) and genotyped using the Sanger sequencing method. Multivariate Cox hazards analysis and multiple testing were applied to estimate the hazard ratio (HR) and 95% confidence intervals (CIs) of all factors possibly associated with RP risk. Results Patients with mean lung disease ≥ 15 Gy and V20 ≥ 24% had higher risk of RP ≥ grade 2 compared with their counterparts (HR = 1.888, 95% CI: 1.186-3.004, P = 0.007; HR = 2.126, 95% CI: 1.338-3.378, P = 0.001, respectively). Importantly, CC + CA genotype of MASP2: rs12711521 was strongly associated with an increased occurrence of RP ≥ grade 2 (HR = 1.949, 95% CI: 1.278-2.971, P = 0.002). Conclusion MASP2: rs12711521 was found to be significantly associated with RP ≥ grade 2 in our cohort and may thus be one of the important predictors of severe RP before radiotherapy, if further validated in larger population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
